Qiagen N.V. (QGEN) Financials

QGEN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 5.8 billion 2.5 billion
Dec. 31, 2025 6.3 billion 2.5 billion
Sept. 30, 2025 6.6 billion 2.9 billion
June 30, 2025 5.8 billion 2.3 billion

QGEN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 53.7 million ?
Dec. 31, 2025 117.2 million 16.6 million
Sept. 30, 2025 119.0 million 10.7 million
June 30, 2025 120.6 million 10.8 million

QGEN Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 68.0 million
Dec. 31, 2025 107.8 million
Sept. 30, 2025 130.0 million
June 30, 2025 96.3 million

QGEN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 646.3 million 1.6 billion -
Dec. 31, 2025 1.1 billion 1.7 billion 157.9 million
Sept. 30, 2025 1.7 billion 1.6 billion -
June 30, 2025 953.8 million 884.8 million -

QGEN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 208.9 million
Dec. 31, 2025 207.8 million
Sept. 30, 2025 218.5 million
June 30, 2025 218.2 million

QGEN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 46.9 million 48.3 million 142.4 million -
Dec. 31, 2025 70.9 million 47.2 million 153.9 million -
Sept. 30, 2025 46.0 million 48.7 million 143.1 million 112.8 million
June 30, 2025 40.8 million 47.8 million 148.7 million 118.1 million

QGEN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 492.3 million 184.4 million
Dec. 31, 2025 540.4 million 223.2 million
Sept. 30, 2025 532.6 million 201.3 million
June 30, 2025 533.5 million 199.3 million

QGEN

Price: $37.56

52 week price:
32.61
57.82

Forward Dividend Yield: 6.42%

Payout Ratio: 377.03%

Payout Ratio Range:
41.71%
1488.21%

Dividend Per Share: 2.41 USD

Earnings Per Share: 1.96 USD

P/E Ratio: 16.65

Exchange: NYQ

Sector: Healthcare

Industry: Diagnostics & Research

Country: Netherlands

Volume: 670300

Ebitda: 103.6 million

Market Capitalization: 6.7 billion

Average Dividend Frequency: 1

Years Paying Dividends: 3

Links: